renal cell carcinoma
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
renal cell carcinoma
Jul 24, 2024, 00:59 |
Blog
Paulo Bergerot: Our first study on Exercise Oncology for patients with RCC
Paulo Bergerot, Medical Oncologist at Oncoclínicas Group, shared a post on X: "Yeah! Our first…
Jul 16, 2024, 20:13 |
Insight
Chinmay Jani: Truly honored to receive the Merit Award
Chinmay Jani, Clinical Fellow, Hematology and Oncology at University of Miami, made the following post…
Jul 15, 2024, 11:30 |
Blog
Neeraj Agarwal: Excellent talk by Michelle Hirsch on the pathology diagnosis of RCC variants
Neeraj Agarwal shared on X: "Surgical Pathology Toolbox and Technological Advances to Solve Kidney Cancer…
Jul 7, 2024, 14:42 |
Blog
Sweta Agrawal: Key Takeaways from Support Group Meeting held for RCC at Patan Hospital in Lalitpur
Sweta Agrawal, Program Coordinator Nepal at The Max Foundation, made the following post on LinkedIn:…
Jul 6, 2024, 08:45 |
Insight
Tom Powles on RCC patients receiving ICI therapy
Tom Powles shared on X: “During the period of PD-1 inhibition availability for RCC in…
Jul 4, 2024, 10:51 |
Blog
Toni Choueiri: Some major changes for systemic therapies in the updated NCCN guidelines are in
Toni Choueiri shared a post on X: "Updated National Comprehensive Cancer Network (NCCN) guidelines (1.2025)…
Jul 1, 2024, 23:51 |
Insight
Piotr Wysocki: Neoadjuvant therapy for renal-cell cancer patients is still in its infancy, unlike in melanoma
Piotr Wysocki recently posted on LinkedIn: "The PROSPER ECOG-ACRIN EA8143 study (published online in Lancet…
Jun 24, 2024, 17:45 |
Blog
The Max Foundation offers three medications for RCC
Sudha Samineni, Program Officer at The Max Foundation, shared on LinkedIn: …
Jun 20, 2024, 14:10 |
Insight
Enrique Grande: Epigenomic signatures of sarcomatoid differentiation of RCC
Enrique Grande shared a post on X: "On Cell Reports - Epigenomic signatures of sarcomatoid…
Jun 19, 2024, 12:33 |
Blog
Maria Babak: How Bevacizumab is revolutionizing treatment for multiple cancers
Maria Babak shared a post by CityU iGEM on LinkedIn: "Discover how Bevacizumab, a powerful cancer…
Jun 3, 2024, 15:09 |
Insight
Avelumab + Axitinib Did Not Improve Overall Survival in Patients with Metastatic Renal Cell Carcinoma: Don't Panic!
"Final overall survival (OS) and progression-free survival (PFS) results for patients with metastatic clear cell…
May 25, 2024, 10:11 |
Insight
Excellent review by Albert Jang and Shilpa Gupta on papillary RCC - Kidney Cancer Journal
Kidney Cancer Journal shared on X: "Just in Kidney Cancer Journal Excellent review by Albert…
May 23, 2024, 13:10 |
Societies
Updated ESMO Clinical Practice Guideline on Renal Cell Carcinoma - ESMO
ESMO – European Society for Medical Oncology posted on LinkedIn: “Updated Renal Cell Carcinoma: ESMO…
May 23, 2024, 06:36 |
Insight
María Natalia Gandur Quiroga: New insights on immunotherapy rechallenge in mRCC
María Natalia Gandur Quiroga shared on X: "New insights on immunotherapy rechallenge in mRCC! Key…
May 19, 2024, 10:12 |
Insight
Erman Akkus: Is oncologic treatment of very advanced disease associated with improved survival?
Erman Akkus, Medical Oncology Fellow at Ankara University shared a post on X: “Is oncologic treatment…
May 17, 2024, 17:18 |
Cancer Types
Renal Cell Carcinoma in Children: What patients and caregivers should know about
What is Renal Cell Carcinoma? Renal cell carcinoma (RCC) is a rare type of kidney…
May 17, 2024, 16:25 |
Cancer Types
Renal Cell Carcinoma in Adults: What patients should know about
What is renal cell carcinoma? Renal cell carcinoma (RCC), also known as renal cell cancer…
May 15, 2024, 12:22 |
Blog
The Babak Lab - Exciting Progress in Melanoma Treatment: Personalized Vaccines Show Promise
Maria Babak, Head of Drug Discovery Lab at City University of Hong Kong, shared a post…
May 12, 2024, 07:40 |
Insight
Yüksel Ürün: Excellent research on plasma Kidney Injury Molecule-1
Yüksel Ürün shared on X: "Congratulations to Wenxin Xu and the team for their excellent…
May 1, 2024, 11:48 |
Insight
Chadi Chehade: Happy to share our editorial recently published in Cancer Cell!
Chadi Chehade, Post-Doctoral Research Fellow at Huntsman Cancer Institute, shared a post by Neeraj Agarwal…
Apr 30, 2024, 11:10 |
Blog
Mohammad Jad Moussa: Proud of Stefan Maksimović, finalist for tripartite 'Lawrence Family Bone Disease Prog of Texas' Awards
Mohammad Jad Moussa, Postdoc Fellow of GU Oncology at MD Anderson Cancer Center, shared on…
Apr 24, 2024, 21:07 |
Blog
Olubukola Ayodele: I had the pleasure of meeting with Daniel Heng, the creator of the IMDC prognostic risk criteria for aRCC
Olubukola Ayodele, Consultant Medical Oncologist at University Hospitals of Leicester Cancer Research Centre, shared a…
Apr 23, 2024, 16:11 |
Blog
Laura Bukavina: Congrats on the award for top poster at IKCSEU24
Laura Bukavina, Assistant Professor of Urologic Oncology at Case Western Reserve University, shared on X:…
Apr 20, 2024, 06:03 |
Insight
Toni Choueiri: The long-awaited OS results from KEYNOTE-564 are out at the New England Journal of Medicine!
Toni Choueiri shared on X/Twitter: "The long-awaited OS results from KEYNOTE-564 are out at the New…
Apr 16, 2024, 13:08 |
Blog
Shilpa Gupta: Great to have Yousef Zakharia, UI Holden Comprehensive Cancer Center talk about updates in kidney cancer
Shilpa Gupta, Director of Genitourinary Oncology at Cleveland Clinic, shared a post on X/Twitter: ''Great…
Apr 11, 2024, 12:10 |
Blog
CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma, by Sumanta K. Pal et al - Cancer Discovery
Cancer Discovery shared on X/Twitter: "Just published with the AACR24 Clinical Plenary presentation: CD70-Targeted Allogeneic CAR…
Apr 8, 2024, 22:02 |
Insight
Renee Maria Saliby: Our paper 'Impact of RCC molecular subtypes on immunotherapy and targeted therapy outcomes' is now published in Cancer Cell
Renee Maria Saliby, Postdoctoral GU Oncology Research Fellow at Dana-Farber Cancer Institute, shared a post on…
Feb 2, 2024, 17:33 |
Drugs
Day 3 of GU24 ASCO Highlights by Oncology Brothers
Oncology Brothers recently tweeted: "Day 3 of GU24 ASCO Highlights 1. KN564: Adj Pembro w/…
Jan 29, 2024, 17:43 |
Insight
Minas Economides: First positive OS trial in adjuvant RCC
Minas Economides, GU Medical Oncologist and Assistant Professor of Medicine at NYU Langone Health, shared…
Jan 18, 2024, 16:11 |
Insight
Erman Akkus: GIMs should be suspected in case of anemia or GI bleeding in patient with a history of RCC
Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X/Twitter: "Gastrointestinal metastasis (GIM) of…
Jan 16, 2024, 01:08 |
Blog
Renee Maria Saliby: Always grateful and fortunate to have David Braun's guidance
Renee Maria Saliby, Postdoctoral GU Oncology Research Fellow at Dana-Farber Cancer Institute, made the following…
Nov 29, 2023, 17:00 |
Insight
Maite Bourlon: Access to novel drugs for metastatic renal cell carcinoma is an unmet need in the Mexican population
Maite Bourlon, Urology Oncologist at the National Institute of Medical Sciences and Nutrition Salvador Zubirán,…
Oct 3, 2023, 18:20 |
Insight
Shankar Siva: Thank you patients, families, trial staff and investigators for participating in TROG (Trans Tasman Radiation Oncology Group) Cancer Research 15.03 FASTRACK II!
Sep 27, 2023, 18:17 |
Insight
Yüksel ÜRÜN: Our paper titled "Adjuvant Therapy for Renal Cell Carcinoma: A Systematic Review of Current Landscape and Future Directions" is now online.
Quoting Yüksel ÜRÜN, Professor at the Ankara University School of Medicine in Turkey, on X/Twitter:…
Aug 9, 2023, 19:51 |
Insight
How chrX alterations may drive sex differences in cancer - Srinivas Viswanathan
Happy to share our latest collaborative preprint with CZ Zhang lab. We studied Xp11 translocation…
Jul 24, 2023, 17:49 |
Blog
Happy to be part of the team - Maite Bourlon
Such a wonderful effort!!! Happy to be part of the team Fernando Sabino M…
All:
36
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube